View in EDS HTML Full Text PDF Full Text

Comparable outcomes with anti-thymocyte globulins versus basiliximab in kidney transplantation from controlled circulatory death donors.

Saved in:

Bibliographic Details
Title:	Comparable outcomes with anti-thymocyte globulins versus basiliximab in kidney transplantation from controlled circulatory death donors.
Authors:	Deslais, Martin¹ (AUTHOR), Koenig, Alice^1,2 (AUTHOR), Buron, Fanny¹ (AUTHOR), Ouellet, Gabriel¹ (AUTHOR), Rabeyrin, Maud³ (AUTHOR), Picard, Cécile³ (AUTHOR), Dijoud, Frédérique³ (AUTHOR), Snanoudj, Renaud⁴ (AUTHOR), Zaidan, Mohamad⁴ (AUTHOR), von Tokarski, Florent⁵ (AUTHOR), Eddine, Arwa Jalal⁵ (AUTHOR), Le Quintrec, Moglie⁶ (AUTHOR), Serre, Jean-Emmanuel⁶ (AUTHOR), Corbel, Alice⁷ (AUTHOR), Flahault, Adrien⁷ (AUTHOR), Giral, Magali^8,9 (AUTHOR), Masset, Christophe^8,9 (AUTHOR), Anglicheau, Dany¹⁰ (AUTHOR), Aubert, Olivier¹⁰ (AUTHOR), Sicard, Antoine¹¹ (AUTHOR)
Source:	Transplant International. 2026, p1-13. 13p.
Database:	Academic Search Ultimate
Full text is not displayed to guests. Login for full access.

Be the first to leave a comment!